Skip to main content
SpringerLink
Log in

Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The effect of a low dose of the glucocorticoid receptor antagonist, RU486, was tested in spontaneously hypertensive (SHR) and in Sprague Dawley (SD) rats. In SD rats, RU486 (50 gmg/day, 18 days) significantly increased growth rate and thymus weight, probably by antagonising the actions of endogenous glucocorticoid hormones. Blood pressure and plasma corticosterone levels were not affected by RU486 at this dose. In leucocytes, RU486 treatment in vivo reduced the number of glucocorticoid binding sites but did not affect binding affinity. In contrast, growth rate and thymus weight were not altered in SHR when treated with the same dose of RU486 for a longer period (60 days). Blood pressure was unaffected as were leucocyte glucocorticoid receptor characteristic. Glucocorticoid receptor binding characteristics for RU486 were similar for liver cytosol of SD and SHR. We conclude that the apparent difference in sensitivity to RU486 between strains is probably not due to differences in interaction of the antagonist with the glucocorticoid receptor but may be caused by differences in pharmacokinetics of RU486 between strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aoki K., Tankawa H., Fujinami T., Miyazaky A., Hashimoto Y. Pathological studies on the endocrine organs of the spontaneously hypertensive rats. Jpn. Heart J. 4: 426, 1963.

    Article  PubMed  CAS  Google Scholar 

  2. Aoki K. Experimental studies on the relationship between endocrine organs and hypertension in spontaneously hypertensive rats. I:effects of hypophysectomy, adrenalectomy, thyroidectomy, nephrectomy and sympathectomy on blood pressure. Jpn. Heart J. 4: 443, 1963.

    CAS  Google Scholar 

  3. Kenyon C.J., DeConti G.A., Cupolo N.A., Morris D.J. The role of aldosterone in the development of hypertension in spontaneously hypertensive rats. Endocrinology 109: 1841, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Hausier A., Girard J., Baumann J.B., Ruch W., Otten U.H. Stress-induced secretion of ACTH and corticosterone during development of spontaneous hypertension in rats. Clin. Exp. Hypert. A5: 11, 1983.

    Article  Google Scholar 

  5. Mullins M., Kleinman L.I., Russell P.T., Srivastava L.S. Plasma aldosterone concentrantrions in neonatal spontaneously hypertensive rats. Life Sci. 31: 2751, 1982.

    Article  PubMed  CAS  Google Scholar 

  6. Yamori Y., Ooshima A., Okamoto K. Metabolism of adrenal corticosteroids in spontaneously hypertensive rats. Jpn. Heart J. 14: 162, 1973.

    Article  Google Scholar 

  7. Sowers J., Tuck M., Asp N.D., Sollars E. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology 108: 1216, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Wexler B.C., McMurtry J.P. Differences in adrenal cholesterol, ascorbic acid, circulating corticosterone and aldosterone during the onset of hypertension in SHR vs WKY rats. Cardiovasc. Res. 16: 573, 1982.

    Article  PubMed  CAS  Google Scholar 

  9. Braley M., Menachery A.I., Williams G.H. Specificity of the alteration in aldosterone biosynthesis in the spontaneously hypertensive rats. Endocrinology 112: 562, 1983.

    Article  PubMed  CAS  Google Scholar 

  10. Ruch W., Baumann J.B., Hausler A., Otten U.H., Siegl H., Girard J. Importance of the adrenal cortex for development and maintenance of hypertension in spontaneously hypertensive rats. Acta Endocrinol. (Copenh.) 105: 417, 1984.

    CAS  Google Scholar 

  11. Kenyon C.J., Panarelli M., Holloway C.D., Dunlop D., Morton J.J., Connell J.M.C., Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J. Steroid Biochem. Molec. Biol. 45: 7, 1993.

    Article  PubMed  CAS  Google Scholar 

  12. Philibert D. RU 38486 an original multifaced antihormone in vivo. In: Agarwal M.K. (Ed.), Adrenal Steroid Antagonism. Walter de Gruyter & Co., Berlin & New York, 1984, p.77.

    Google Scholar 

  13. Jung-Testas J., Baulieu E.E. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU486, a new antiglucocorticosteroid of high affinity for glucocorticosteroid receptor. Exp. Cell. Res. 147: 177, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Bertagna X., Bertagna C., Luton J.-P., Husson J.-M., Girard F. The new steroid analog RU486 inhibits giucocorticoid action in man. J. Clin. Endocrinol. Metab. 59: 25, 1984.

    Article  PubMed  CAS  Google Scholar 

  15. Kalimi M. Role of antiglucocorticoid RU486 on dexamethasone-induced hypertension in rats. Am. J. Physiol. 256: E682, 1989.

    PubMed  CAS  Google Scholar 

  16. Grünfeld J.-P., Eloy L., Moura A.-M., Ganeval D., Ramos Frendo B., Worcel M. Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. Hypertension 7: 292, 1985.

    Article  PubMed  Google Scholar 

  17. Opoku J., Kalimi M. Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension. Acta Endocrinol. (Copenh.) 127: 258, 1992.

    CAS  Google Scholar 

  18. Laue L., Chrousos G.P., Loriaux D.L., Barnes K., Munson P., Nieman L.K., Schaison G. The antiglucocorticoid and antiprogestin steroid RU486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. J. Clin. Endocrinol. Metab. 66: 290, 1988.

    Article  PubMed  CAS  Google Scholar 

  19. Van Voorhis B., Anderson D.J., Hill D.J. The effects of RU486 on immune fuction and steroid-induced immunosuppression in vitro. J. Clin. Endocrinol. Metab. 69: 1195, 1989.

    Article  PubMed  Google Scholar 

  20. Panarelli M., Holloway C.D., Mulatero P., Fraser R., Kenyon C.J. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leucocytes: an index of glucocorticoid sensitivity. J. Clin. Endocrinol. Metab, 78: 872, 1994.

    PubMed  CAS  Google Scholar 

  21. Nieman L.K., Loriaux D.L. Clinical applications of the glucocorticoid and progestinic antagonist RU486. In: Agarwal M.K. (Ed.), Receptor-mediated Antisteroid Action. Walter de Gruyter, New York, 1987, p. 78.

    Google Scholar 

  22. Tonolo G., Fraser R., Connell J.M.C., Kenyon C.J. Chronic low dose infusions of dexamethasone in rats: effects on blood pressure, body weight and plasma atrial natriuretic peptide. J. Hypert. 6: 25, 1988.

    CAS  Google Scholar 

  23. Evans A.L., Brown W., Kenyon C.J., Maxted K.J., Smith D.C. An improved system for measuring systolic blood pressure in the conscious rat. Med. Biol. Eng. Comput. 32(1): 101, 1994.

    Article  PubMed  CAS  Google Scholar 

  24. Morton J.J., Kenyon C.J., Beattie E.C. Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats. J. Hypert. 8: 1021, 1990.

    Article  CAS  Google Scholar 

  25. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21(Suppl. 97): 77, 1968.

    Google Scholar 

  26. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for characterisation of ligand system. Anal. Biochem. 107: 220, 1980.

    Article  PubMed  CAS  Google Scholar 

  27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol.Chem. 193: 265, 1951.

    PubMed  CAS  Google Scholar 

  28. Kenyon C.J., Brown W.B., Fraser R., Tonolo G., McPherson F., Davies D.L. Effects of dexamethasone on body fluid and electrolyte composition of rats. Acta Endocrinol (Copenh.) 122: 599, 1990.

    CAS  Google Scholar 

  29. Brownie A.C., Alfano J., Gallant S. Rat models of experimental hypertension:their adrenocortical components. In: Biglieri E.G., Melby J.C. (Eds.), Endocrine hypertension. Raven Press, New York, 1990, p. 29.

    Google Scholar 

  30. Laux M, Bauer H., Ganten U., Zimmerman F., Vecsei P. Glucocorticoid receptors and dissociation constants are decreased in mononuclear leucocytes of spontaneously hypertensive rats (SHR-SP) as compared to normotensive Wistar-Kyoto rats (WKY). J. Steroid Biochem. 34: 331, 1989.

    Article  PubMed  CAS  Google Scholar 

  31. Panarelli M., Holloway C.D., Barr A., Fraser R., Kenyon C.J. Differences in temperature-sensitive receptor binding of glucocorticoids in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY). J. Endocrinol. 137(Suppl.): P25, (Abstract), 1993.

    Google Scholar 

  32. Kalimi M., Agarwal M.K. Interaction of antiglucocorticoid RU486 with rat kidney glucocorticoid receptor. Biochem. Biophys. Res. Comm. 153: 365, 1988.

    Article  PubMed  CAS  Google Scholar 

  33. Agarwal M.K., Lombardo G., Eliezer N., Moudgil V.K. Activation of rat liver glucocorticoid receptor bound to the antiglucocorticoid RU38486. Biochem. Biophys. Res. Commun. 133: 745, 1985.

    Article  PubMed  CAS  Google Scholar 

  34. Spitz I.M., Heikinheimo O., Wade C.E. The divergent effect of RU486 on adrenal function in the dog is related to differences in its pharmacokinetics. Acta Endocrinol. (Copenh.) 128: 459, 1993.

    CAS  Google Scholar 

  35. Deraedt R., Bonnat C., Busigny M., Chatelet P., Cousty C., Mouren M., Philibert D., Pottier J., Salmon J. Pharmacokinetics of RU486. In: Baulieu EE & Segal SJ (Eds.), The antiprogestin steroid RU486 and human fertility control. Plenum, 1985, p. 103.

  36. Morris D.J., Kenyon C.J. Aldosterone and its metabolism in spontaneously hypertensive rats (SHR). Clin. Exp. Hypertens. A4: 1613, 198

    Article  CAS  Google Scholar 

  37. Watlington C.O., Kramer L.B., Schetz E.G., Zilai J., McLean Grogan W., Guzelian P., Gizek F., Schoolworth A.C. Corticosterone 6β-hydroxylation correlates with blood pressure in spontaneously hypertensive rats. Am. J. Physiol. 262: F927, 1992

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland, UK

    Aldo Soro, M. Panarelli, C. D. Holloway, R. Fraser & C. J. Kenyon

Authors
  1. Aldo Soro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Panarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. D. Holloway
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Fraser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. J. Kenyon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soro, A., Panarelli, M., Holloway, C.D. et al. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats. J Endocrinol Invest 18, 833–839 (1995). https://doi.org/10.1007/BF03349829

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349829

Key-words

Search

Navigation